(Q40998257)

25 September 2017

Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system (English)

1 reference

25 September 2017

0 references

0 references

V K Pestonjamasp

1

1 reference

PubMed ID

9795237

25 September 2017

S H Burstein

series ordinal

2

1 reference

25 September 2017

1 November 1998

1 reference

Biochimica et Biophysica Acta

25 September 2017

1 reference

25 September 2017

1394

1 reference

25 September 2017

249-260

1 reference

25 September 2017

2-3

1 reference

Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'.

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by delta 9-tetrahydrocannabinol (THC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Phospholipase participation in cannabinoid-induced release of free arachidonic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Alterations of fatty acyl turnover in macrophage glycerolipids induced by stimulation. Evidence for enhanced recycling of arachidonic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

The endogenous cannabimimetic eicosanoid, anandamide, induces arachidonate release in J774 mouse macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Platelet-activating factor: receptors and signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Altered responses to modulators of guanine nucleotide binding protein activity in endotoxin tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Metabolic interactions between eicosanoids in blood and vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

The eicosanoids and their biochemical mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Marijuana, receptors and immunomodulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Do endogenous cannabinoids contribute to HIV-mediated immune failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

The dynamics of prostaglandin H synthases. Studies with prostaglandin h synthase 2 Y355F unmask mechanisms of time-dependent inhibition and allosteric activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900110-6

10.1016/S0005-2760(98)00110-6

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

9795237